- A new health tech fund, the Special Opportunities Fund, has been launched to invest in impactful innovations.
- The fund’s first investment is in Braingaze, a tool that uses eye tracking to diagnose ADHD quickly and enable drug-free treatment.
- The fund is a collaboration between charity Future Care Capital and investment fund manager RYSE Asset Management.
- The goal of the fund is to support early-stage companies that can address challenges in healthcare delivery systems and improve patient outcomes.
- Braingaze aims to address the long wait times for ADHD diagnosis in the UK and contribute to the cognitive care innovation ecosystem.
New Health Tech Fund Revolutionizing Healthcare Investments
In the realm of healthcare innovation, a new player has emerged to make a significant impact on the industry. The Special Opportunities Fund, spearheaded by charity Future Care Capital (FCC) and managed by RYSE Asset Management, is set to revolutionize the way investments are made in health technology. The fund’s primary focus is to support groundbreaking technologies that have the potential to transform care delivery systems and enhance patient outcomes.
Braingaze: A Game-Changing Diagnostic Tool for ADHD
One of the first investments made by the Special Opportunities Fund is in Braingaze, a revolutionary diagnostic tool that utilizes eye tracking technology to diagnose ADHD in a matter of minutes. This innovative tool not only speeds up the diagnostic process but also offers drug-free cognitive disorders treatment, bringing a new dimension to brain-related healthcare. With the current challenges in healthcare systems, such as long wait times for diagnoses and shortages of medication, Braingaze presents a timely solution that can significantly impact the lives of individuals affected by ADHD.
Collaborative Efforts for Transformative Impact
The partnership between FCC and RYSE Asset Management in establishing the Special Opportunities Fund highlights a collaborative effort to drive positive change in the healthcare ecosystem. By engaging institutional and qualified investors, the fund aims to provide crucial financial support to early-stage companies with innovative solutions that address the pressing challenges faced by healthcare systems globally. This unique approach not only seeks to deliver financial returns but also to make a tangible difference in improving the quality of life and well-being of individuals.
Related Video
Leading the Way in Healthcare Innovation
The leadership behind the Special Opportunities Fund is committed to fostering innovation and leveraging technology to enhance care delivery. Andrew Whelan, Chair at FCC, emphasizes the fund’s mission to support investments aligned with the charitable goal of improving health and care. Through strategic investments in cutting-edge technologies like Braingaze, the fund aims to create sustainable impact and drive positive change in the healthcare landscape.
As the demand for innovative healthcare solutions continues to grow, the Special Opportunities Fund stands at the forefront of driving progress and accelerating the adoption of digital solutions that improve patient outcomes. With a strong focus on social impact and financial sustainability, the fund sets a new standard for healthcare investments that prioritize both humanitarian goals and financial returns.
The launch of the Special Opportunities Fund marks a significant milestone in the realm of health tech investments, paving the way for transformative innovations that have the potential to revolutionize healthcare delivery. Through strategic partnerships, visionary leadership, and a commitment to making a positive impact, the fund is poised to lead the charge in shaping the future of healthcare through technology and innovation.
Links to additional Resources: 1. https://www.braingaze.com/ 2. https://www.additudemag.com/ 3. https://www.chadd.org/